Some Bio Companies Had Muted Development in 2020 Due to Covid but are Now Taking Off, and We Have One that Looks Ready for Takeoff with a Golden Cross Chart Formation.

Some Bio Companies Had Muted Development in 2020 Due to Covid but are Now Taking Off, and We Have One that Looks Ready for Takeoff with a Golden Cross Chart Formation.

Good day everyone,

The major stock indices are looking strong with the DJIA at 36,100 and the NASDAQ at 15,860. While those numbers have surpassed my self-proclaimed resistance levels of 36,000 and 15,000 respectively, I’m still looking for a breakout in the near to mid-term.

A recent WSJ article implied that investors are moving toward small-cap companies with the belief that smaller companies can react more quickly to inflationary pressures. That’s good news for our members. Large companies aren’t nimble, particularly in response to increasing costs from vendors. Their supply contracts are often long termed and complex making it difficult to change suppliers to avoid inflationary pressures.

I will be reporting on a NASDAQ company I’ve talked about in the past. I’ve watched this company for a few years and reported on them more than once. This is a company that can produce catalysts a few times a year as they grow. As those catalysts have come forth, I’ve reported on this company and the benefit to our members has been significant each time.

The company is in the bio sector and like many of its peers, 2020 was a muted year due to the pandemic. Development wasn’t halted but continued at a slow pace. But 2021 has been a different story and the progress this company has made this year is admirable. More importantly, I’ve identified multiple potential catalyst that are happening right now that are causing the company’s value to trend and could indicate a near-term breakout.

Stay tuned and stay informed. We will issue a report on this company Tuesday, November 16, 2021, near market open.

The Traders News Breakout Group

 

 

Privacy Policy and Disclaimer